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Introduction {#s1}
============

Cusco, Peru, is a popular travel destination in the Andes mountain range that is famous for its archaeological remains, including Machu Picchu. Previous studies have identified Cusco as a destination associated with a high risk of acute travelers\' diarrhea (TD), with U.S. travelers at higher risk than those from other countries (adjusted odds ratio \[OR\] = 1.28; 95% confidence interval \[CI\] = 1.09--1.50).[@ref1]

However, in Cusco, and South America in general, the specific etiologies of TD have not been well evaluated, and the clinical features associated with pathogen-specific infections, along with destination-specific risk behaviors, remain largely uncharacterized. Understanding these factors would allow travel medicine providers to tailor interventions to patients\' risk profiles and travel destination.[@ref2]

Anticipatory guidance and interventions (e.g., immunizations and prophylaxis) aim to decrease the incidence of travel-related injury and illness. Previous work shows that 94% of travelers to Cusco seek some sort of pretravel preventive guidance.[@ref3]

However, North American travelers to Peru are less likely than western European travelers to seek pretravel preventive medical advice from a travel medicine practitioner (37% versus 45.8%, *P* \< 0.01) and from a health-care professional (52.0% versus 67.1%, *P* \< 0.01).[@ref3],[@ref4]

Further, current health-related guidelines and dietary precautions have little evidence of effect on the incidence of TD.[@ref5]--[@ref7]

Although most patients with TD experience spontaneous symptom resolution, some may experience symptoms for weeks,[@ref8] and up to half of travelers change travel plans as a result of symptoms.[@ref5]

Of note, immunocompromised patients from high-income countries are traveling at increasing rates, and their increased risk for developing disease highlights the importance of providing effective preventive recommendations and measures for such complex patients.[@ref9] The development of subsequent irritable bowel syndrome has become an increasingly recognized risk in the past decade,[@ref10] reported by up to 1/5 of returning travelers with TD.[@ref5]

Thus, the benefits of reducing TD incidence extend beyond the travel period.

Traditionally, TD has been difficult to characterize because most data are derived from sentinel surveillance systems, which often lack denominator data and asymptomatic controls for comparison. A case--case approach allows a comparison of symptom severity between pathogens identified in the stool, although it lacks mechanisms to question if a particular pathogen present in the stool is causally related to diarrheal disease. A case--case approach allows restricted and refined analysis of some unique exposures associated with different pathogens detected through a surveillance system.[@ref11]--[@ref13]

Although the approach reduces selection and recall bias relative to case--control formats[@ref14] by ensuring that both case and "control" subjects were all affected by similar disease, the design does remain vulnerable to other forms of selection bias, that is, greater selection of infected travelers with severe symptoms compared with milder symptoms. To describe the etiology of medically attended TD, evaluate regional risk factors, and examine relationships between preventive recommendations and risk-taking behaviors among medium- to long-term travelers from high-income countries, we conducted this case--case analysis of 7 years of prospective surveillance data from adults presenting to a physician in Cusco with TD.

Materials and Methods {#s2}
=====================

Ethics statement. {#s2a}
-----------------

This study was approved by the institutional review boards of Naval Medical Research Unit No. 6 and Universidad Peruana Cayetano Heredia. Participants provided written informed consent at the time of enrollment.

Study population. {#s2b}
-----------------

Between June 2003 and July 2010, we prospectively enrolled Spanish language students presenting consecutively with acute diarrhea to the Amauta Spanish School\'s physician. Male and female students, older than 18 years, from countries with low-to-moderate risk of TD, and seeking free medical attention were included.[@ref15]

We defined diarrhea as three or more loose or watery stools, or two loose or watery stools accompanied by nausea, vomiting, abdominal cramping/pain, or tenesmus, within a 24-hour period.[@ref16],[@ref17]

To reduce confounding by chronic or recently treated diarrhea, students who could not provide a stool sample at the time of presentation, had taken antimicrobial medications within the week prior to presentation, reported chronic diarrhea, or did not speak English were excluded.

Survey administration, sample collection, pathogen identification, and antimicrobial resistance testing. {#s2c}
--------------------------------------------------------------------------------------------------------

Using a standardized form, a trained health-care worker surveyed enrollees to determine age, gender, country of birth, country of residence, lodging, and length of stay in Cusco, and Peru, in addition to TD risk factors, such as history of previous episodes, comorbidities, preventive measures, location and type of foods ingested, and clinical features of the presenting episode. Nonrecommended foods were defined using standard lists of unsafe foods.[@ref2]

We collected survey responses from individual cases while waiting for laboratory results to further reduce information and recall bias. The collection of individual-level data permitted us to control for potential confounding.

Participants provided fresh stool samples for analysis. Upon collection, specimens were kept fresh in preservative-free containers and transported in Cary Blair media to a central reference laboratory (ServiSalud) in Cusco city for bacteria and parasite analyses. On arrival, stool specimens went through a microscopic examination looking for ova and parasites using saline wet preparations to detect protozoa and helminth infections. The Ritchie method[@ref18] was used to identify *Giardia* spp. Cary Blair specimens were cultured for *Campylobacter*, *Escherichia coli*, *Salmonella*, *Shigella*, *Aeromonas*, and *Plesiomonas* using conventional microbiologic techniques.[@ref18]--[@ref20]

We performed polymerase chain reaction (PCR) on five lactose-fermenting colonies morphologically resembling *E. coli* to identify heat labile and stable enterotoxigenic (ETEC), enteropathogenic (EPEC), and enteroaggregative (EAEC) *E. coli*.[@ref21]

Antibiotic susceptibility testing was performed using the disk diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines.[@ref22]

The isolates were tested against the most commonly used antimicrobial agents: ampicillin, amoxicillin--clavulanic acid, cefazolin, ceftriaxone, erythromycin, azithromycin, nalidixic acid, ciprofloxacin, gentamicin, sulfamethoxazole--trimethoprim, and tetracycline.[@ref22]

In the case of azithromycin, because of the absence of an established breakpoint, minimal inhibitory concentration was also determined by the agar dilution method according to CLSI guidelines[@ref22] on all isolates with an inhibitory halo \< 15 mm.[@ref23]

We combined intermediate and resistant isolates for analysis purposes. To determine Enterobacteriaceae susceptibility given lack of breakpoints published in CSLI, our laboratory used *Staphylococcus aureus* for quality control, and then established a resistance cutoff of 16 mm[@ref24] with a susceptible strain of *E. coli* 25922.[@ref22],[@ref25]--[@ref28]

After preparing fresh specimens for parasite identification, the remaining stool was frozen and sent to Naval Medical Research Unit No. 6 (NAMRU-6) in Lima, Peru, for additional parasite testing using microscopy and commercial enzyme-linked immunosorbent assay (ELISA) kits for *Entamoeba histolytica* (TechLabs, Blacksburg, VA), *Giardia lamblia* (BioTech Trading Partners), and *Cryptosporidium* (BioTech Trading Partners, Encinitas, CA). *Cryptosporidium*-positive results were confirmed by PCR. Samples positive by microscopy but negative by ELISA were considered positive; in any further cases of discrepancy between results of pathogen identification at ServiSalud and NAMRU-6, NAMRU-6 results were considered confirmatory. A suspension of each stored stool specimen (10% w/v) was prepared in phosphate-buffered saline and RNA extracted using the Qiagen QIAmp Viral RNA Kit (Valencia, CA) in accordance with the manufacturer\'s instructions. Viral RNA was tested for Norovirus (NV) GI and GII by real-time PCR.[@ref29]

A sample was considered positive if the negative control did not exhibit fluorescent curves. The threshold cycle for the sample was at least 37 for NV GI and 39 for GII.

Statistical analysis. {#s2d}
---------------------

Statistical analysis was performed using Stata version 13.0 (StataCorp LP, College Station, TX). By convention, *P* values \< 0.05 were considered statistically significant. Exploratory analysis of participant demographics, diarrhea risk factors, and clinical features of illness was performed using the two-tailed Student\'s *t* test to compare continuous variable means for normally distributed variables, Wilcoxon rank-sum tests for nonparametric continuous variables, and Fisher\'s exact test to compare proportions. We used dichotomous variables to characterize any versus no exposure to individual diarrhea risk factors. After excluding individuals coinfected with more than one pathogen, we performed a case--case analysis to examine the association of single-pathogen infections with dietary risk factors, according to the methods of Wilson and others.[@ref30]

It is standard practice in a case--case analyses to take the most prevalent or most frequently notified cause as the referent or comparison group.[@ref30]

We selected ETEC as the case--case analysis reference group because it is the most commonly implicated pathogen worldwide,[@ref2] has the added benefit of being the most frequently identified cause of TD in Latin America, and has well characterized risk factors and clinical feature profiles.[@ref17]

We considered age and gender to be confounders a priori,[@ref13],[@ref14] and controlled for them using multiple logistic regression. Exploratory analysis did not identify additional potential confounding factors.

Results {#s3}
=======

Demographics. {#s3a}
-------------

During the 7-year passive surveillance period, 230 adults (66% female) aged 18--76 (median = 24, interquartile range \[IQR\] = 7) years with diarrhea were enrolled in the study ([Table 1](#tab1){ref-type="table"}). Participants were permanent residents of 17 countries, 75% were European, 21.3% North American, and 3.5% Australian. The mean length of stay in Cusco was 45 days (median = 28, range = 1--548, IQR = 52). The diarrhea incidence among cases was 2.2 episodes per 90 person-days (230/9,417.5) in Cusco.

Reported diarrhea risk factors. {#s3b}
-------------------------------

During the week before presenting with diarrhea, 47% of participants ate the majority of meals in a restaurant, 15.2% in a friend\'s home, 13% in a hotel, and 24.8% in an "other" location ([Table 1](#tab1){ref-type="table"}). All participants reported consuming at least one of the following risky food items time during the week before illness: fruit juice (86%), cheese (78%), raw green vegetables (72%), cold sauces (52%), milk (46%), ice (40%), reheated buffet foods (38%), ice cream (33%), unpeeled fruit (29%), street vendor food (28%), the local drink chicha (25%), and tap water (14%) ([Table 2](#tab2){ref-type="table"}).

Approximately two-thirds (176/230) of study participants reported receiving advice to prevent diarrhea. These individuals reported following this guidance all (46%), some (51%), or none (3%) of the time. Among those who reported always following recommendations, 93% (84/90) reported consuming three or more of the abovementioned foods linked to TD. Among these three stratified risk groups, the majority consumed fruit juice (84%, 86%, and 83%), cheese (73%, 83%, and 83%), or raw green vegetables (58%, 81%, and 83%), and the majority (84%) of the group that reported always following recommendations also consumed at least three foods linked to TD. In addition, 55/230 (24%) study participants took medications to prevent diarrhea, at some time prior to 1 week before enrollment. Of these individuals, 50 provided information on the type of medication used: 32% had taken antibiotics, 4% took bismuth preparations, and 64% took "other" medications.

Pathogen identification. {#s3c}
------------------------

A pathogen was identified in 45% of 230 cases ([Table 3](#tab3){ref-type="table"}). NV was identified in 14% of samples (6 GI, 26 GII), ETEC in 11%, *Campylobacter* in 9%, *Shigella* in 6%, EAEC in 4%, *Giardia* in 4%, and *Cryptosporidium* in 3%. No EPEC, *E. histolytica*, *Salmonella*, *Aeromonas*, or *Plesiomonas* were detected. Coinfections with more than one pathogen were identified in 12 (5%) participants. Coinfections were most frequent among cases infected with the parasites *Giardia* (44%, 4/9) and *Cryptosporidium* (43%, 3/7). Coinfections were also found in individuals infected with ETEC (28%, 7/25 ETEC cases) in combination with NV (19%, 6/32 NV cases), EAEC (11%, 1/9 EAEC cases), and *Campylobacter* (10%, 2/20 *Campylobacter* cases). NV and ETEC were most frequently identified together (*N* = 6 coinfected cases), followed by *Cryptosporidium* and *Giardia* (*N* = 2 coinfected cases). Coinfections with the following pathogens were each observed once: EAEC and NV, ETEC and *Giardia*, *Campylobacter* and *Cryptosporidium*, and *Campylobacter* and *Giardia*. *Giardia* was a coinfecting agent in the greatest number of pathogen combinations (three other pathogens). No *Shigella* cases were coinfected. [Table 4](#tab4){ref-type="table"} shows bacterial antimicrobial resistance patterns, and [Table 5](#tab5){ref-type="table"} shows the relationship between pathogen prevalence and seasonality.

TD clinical features and severity. {#s3d}
----------------------------------

Gastroenteritis episodes were most frequently associated with watery diarrhea (84%), abdominal cramping/pain (76%), loss of appetite (69%), fatigue (68%), and gas/bloating (63%) ([Table 2](#tab2){ref-type="table"}). Subjective fever was reported in 42% of TD cases, most frequently with *Campylobacter* (75%), *Shigella* (71%), and EAEC (67%). Thirty-four percent of cases reported vomiting. Fifty-six percent of those with EAEC and 50% of those with NV (13/26 GII, 3/6 GI) vomited. Ten percent reported bloody diarrhea, most often with *Shigella* (36%), *Giardia* (22%), *Campylobacter* (20%), ETEC (16%), and NV GII (9%); no NV GI case had bloody diarrhea. These statistics include two individuals who were coinfected with NV GII and ETEC, along with one individual coinfected with *Campylobacter* and *Giardia*. Of the 230 cases, two were hospitalized, 62% stayed in bed, 52% saw a physician, 23% missed a scheduled tour, 13% made a change in travel itinerary, and 18% reported no effect on daily activities. One hospitalized case had no pathogen identified; one was positive for *Cryptosporidium*. Both were females aged 23 who presented in the winter and reported consuming raw green vegetables, fruit juice, and cheese. Neither had chronic gastritis. The case with no pathogen was from Holland, stayed in Cusco for 2 weeks in the winter, and reported she always followed preventive recommendations. The *Cryptosporidium* case was from Belgium, stayed in Cusco for 2 months in the winter, gave no answer regarding following recommendations, and reported consuming chicha. Ninety-one percent of norovirus-associated diarrhea cases were confined to bed. ETEC and *Shigella* cases had the largest proportion of doctors\' visits, 60% and 79%, respectively.

Case--case analysis. {#s3e}
--------------------

In the unadjusted case--case analysis of diarrhea risk factors, individuals with and without ETEC ate at similar locations and had similar food exposures during the week before illness. However, individuals infected with NV GII were significantly less likely to have consumed reheated buffet food (OR = 0.10, 95% CI = 0.01--0.91), and individuals infected with NV overall were significantly less likely to have consumed food from street vendors (OR = 0.11, 95% CI = 0.01--0.88) relative to those with ETEC, although the buffet food relationship did not persist when the NV strains were combined. Chicha consumption was significantly associated with *Cryptosporidium* (OR = 5.44, 95% CI = 1.1--27.3) and EAEC (OR = 7.33, 95% CI = 1.17--46.1) infections relative to infection with ETEC. Individuals with no pathogen detected were significantly less likely to have consumed ice cream in the past week relative to ETEC (OR = 0.40, 95% CI = 0.17--0.94). Being a permanent resident of the United States or staying in Cusco longer than 1 week were not significantly associated with any pathogen relative to ETEC (data not shown). After adjusting for the potential confounders of age and gender, the statistical significance, OR magnitude, and CI size of these associations remained unchanged ([Table 6](#tab6){ref-type="table"}).

Discussion {#s4}
==========

This study is one of the first to evaluate TD among medium- to long-term adult travelers to South America. The 28-day median length of stay reported by participants exceeds the 5-day median stay in Cusco reported previously by travelers[@ref1] and also the 17-day median stay in a study of global travelers with TD.[@ref31]

Thus, these results may be generalizable to backpackers, international students, individuals involved in volunteer/service programs, and military populations deployed to this region.

We most frequently identified NV (14%), ETEC (11%), and *Campylobacter* (9%) in participants with TD, which differs from the results of a recent review identifying ETEC (33%), NV (15%), and EAEC (13%) as the top three TD pathogens in Latin America.[@ref17]

Although the lack of reported CIs in this comprehensive review does not allow us to comment on the level of significance of this observation, this suggestion of a lower prevalence of ETEC could be due to the inclusion of more severe diarrhea cases among longer-term travelers, along with the absence of NV detection methods in previous TD studies. While cholera vaccination provides some protection against ETEC,[@ref32] we did not systematically assess this exposure. Of two participants who volunteered vaccination status, ETEC was missing for one and negative for the other, which would not appreciably impact ETEC prevalence. The study methodology was limited by a lack of capability to perform molecular testing for the full range of viral pathogens. For example, we might expect to detect Sapovirus among adult travelers to Cusco,[@ref33] and data on Rotavirus and Astrovirus could also provide new information if included in future analyses. A recent systematic review of TD from 1973 to 2009 only included one study evaluating NV among travelers to Latin America, with a prevalence of 17% among students traveling to Mexico.[@ref17]

Globally, NV is the most common cause of all varieties of diarrhea, accounting for double the number of cases as ETEC,[@ref34] and diarrheagenic *E. coli* and NV are commonly identified among Latin American travelers with TD.[@ref35]

Coinfection in this study was common, with half of coinfected TD cases positive for both NV and ETEC, and almost half of coinfected cases testing positive for *Giardia*. NV and ETEC were implicated together in a 2008 gastroenteritis outbreak among U.S. Navy personnel visiting Lima,[@ref36] and both generally indicate a high level of fecal contamination in the environment. In coinfected travelers, NV is believed to contribute to disease, although detection may be attributable to prolonged viral shedding following a previous symptomatic or asymptomatic NV infection.[@ref17],[@ref37],[@ref38]

*Giardia* was also frequently detected in coinfected cases in our study, making it worthwhile to note that a recent debate in the literature emphasizes the commensal gut bacteria role that *Giardia* may play for citizens of countries where it is endemic.[@ref39]--[@ref41]

Excluding participants with chronic diarrhea could have underestimated the contribution of parasites to diarrhea, while excluding those with recent antibiotic use could have impacted the prevalence of antimicrobial resistant pathogens. The exclusion of individuals who could not provide a stool sample at the time of presentation may have biased this study toward the evaluation of cases with particularly severe disease, which assists in the identification of pathogens against which preventive measures might be most impactful. Our population experienced a high rate (62%) of bed confinement, similar to rates reported in military members with TD (52%).[@ref31]

Compared with 4% bed confinement rates among adult Peruvians with NV-associated diarrhea,[@ref42] NV-infected travelers with TD reported 91% bed confinement, suggesting that preventive measures, such as vaccines, directed against this pathogen could significantly reduce the burden of disease. Given TD\'s mission aborting potential for military troops,[@ref43] in whom incapacitation could pose a further threat to life,[@ref33],[@ref42] recommendations to military members operating in this geographic area should take NV-associated risks into account.

This study has several travel medicine implications. First, the prevalence of ciprofloxacin-resistant *Campylobacter* in our study reinforces the existing recommendations to empirically treat severe TD with azithromycin.[@ref44]

Our data also suggest that individuals who reported always following preventive recommendations took relatively fewer risks; however, these individuals still engaged in risky behaviors, indicating a possible gap in traveler receipt or understanding of preventive recommendations, or reflecting the difficulty of full compliance with all travel recommendations. In addition to supporting the use of pretravel interventions, such as vaccines, this may indicate that pretravel guidance is not sufficiently region or country specific, as noted by other authors.[@ref31]

Case--case analysis identified ice cream consumption as a risk factor for ETEC compared with cases with no pathogen identified, which, depending on method of milk preparation, could be consistent with the literature showing that ETEC is associated with unpasteurized dairy products.[@ref45]

For instance, the "queso fresco" and other cheeses typical of the Andean diet are often unpasteurized. Case--case analysis identified buffet food and street vendor food as risk factors for ETEC compared with NV GII, as well as an association between chicha with both *Cryptosporidium* and EAEC, which, despite wide CIs, should be considered for future travel medicine recommendations.

Given the case--case methodology, study limitations include the binomial outcome requirement for statistical analysis and the conservative estimates of association it provides given that most TD pathogens share risk factors.[@ref30]

In conclusion, NV was the most frequently identified pathogen among medium- to long-term adult travelers from high-income countries presenting to a physician in Cusco with TD. ETEC and *Campylobacter*, notably ciprofloxacin-resistant *Campylobacter*, were also frequently identified, and coinfection with multiple enteropathogens was common. NV caused severe disease relative to other TD-associated pathogens identified, confining over 90% of infected individuals to bed. Destination-specific risk factors include consumption of the local beverage chicha, which was associated with *Cryptosporidium* infection.
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###### 

Demographic characteristics, protective behaviors, and risk factor frequencies for participants

  Variable                                         Mean or frequency   Percent[\*](#tfn2){ref-type="table-fn"}   Observations   Missing (%)   Standard deviation
  ------------------------------------------------ ------------------- ----------------------------------------- -------------- ------------- --------------------
  Demographic factors                                                                                                                         
   Age, years                                      26.9                                                          230            0             9.6
   Gender (female)                                 152                 66.1                                      230            0             
   Length of stay in Cusco, days                   44.85                                                         210            8.7           60.7
   Season (summer/rainy)                           100                 43.5                                      230            0             
   Country of Residence                                                                                          230            0             
    Netherlands                                    53                  23.0                                                                   
    United Kingdom                                 44                  19.1                                                                   
    United States                                  40                  17.4                                                                   
    Europe, other[†](#tfn3){ref-type="table-fn"}   36                  15.7                                                                   
    Switzerland                                    22                  9.6                                                                    
    Germany                                        20                  8.7                                                                    
    Canada                                         9                   3.9                                                                    
    Australia                                      6                   2.6                                                                    
  Protective factors against TD                                                                                                               
   Received advice                                 176                 76.5                                      230            0             
   Followed all recommendations                                                                                  195            15.2          
    Never                                          6                   3.1                                                                    
    Sometimes                                      99                  50.8                                                                   
    Always                                         90                  46.2                                                                   
   Took medications to prevent TD (yes)            55                  23.9                                      230            0             
    If yes, what medications?                                                                                    50             2.2           
     Antibiotics                                   16                  32.0                                                                   
     Other                                         32                  64.0                                                                   
     Bismuth                                       2                   4.0                                                                    
  Risk factors                                                                                                                                
   Location of majority of meals in past week                                                                    230            0             
    Restaurant                                     108                 47.0                                                                   
    Other                                          57                  24.8                                                                   
    Friend\'s home                                 35                  15.2                                                                   
    Hotel                                          30                  13.0                                                                   

TD = travelers\' diarrhea.

Percent of number of observations for each variable.

Austria, Belgium, Czech Republic, Denmark, Finland, France, Italy, Israel, Turkey, Spain, and Sweden.

###### 

Signs, symptoms, stool characteristics, and effect of daily activities among those positive for given pathogens, or negative for all pathogens

                                                           Total   Pathogen                                                                              
  -------------------------------------------------------- ------- ---------- ----- ---- --- ----- ---- ---- ---- ---- --- ----- --- ---- ---- ---- ---- -----
  Signs and symptoms                                                                                                                                     
   Fatigue                                                 156     68         79    63   8   89    18   72   15   75   5   71    5   56   24   75   11   79
   Gas or bloating                                         145     63         79    63   2   22    16   64   11   55   6   86    8   89   18   56   11   79
   Nausea                                                  113     49         58    46   6   67    11   44   11   55   5   71    2   22   15   47   9    64
   Vomiting                                                79      34         38    30   5   56    9    36   6    30   3   43    3   33   16   50   3    21
   Fever                                                   96      42         45    36   6   67    8    32   15   75   1   14    3   33   13   41   10   71
   Abdominal cramping/pain                                 174     76         88    70   9   100   21   84   14   70   7   100   7   78   27   84   12   86
   Loss of appetite                                        158     69         79    63   7   78    15   60   16   80   6   86    8   89   24   75   12   86
   Loss of weight                                          80      35         44    35   2   22    10   40   7    35   5   71    6   67   11   34   2    14
  Characteristics of stool                                                                                                                               
   Loose                                                   114     50         72    58   2   22    10   40   7    35   5   71    4   44   12   38   7    50
   Bloody                                                  23      10         8     6    1   11    4    16   4    20   0   0     2   22   3    9    4    29
   Watery                                                  193     84         99    79   8   89    23   92   19   95   7   100   7   78   31   97   10   71
   Mucus                                                   41      18         21    17   1   11    5    20   4    20   1   14    0   0    5    16   5    36
  Dietary risks (one or more exposures in the past week)                                                                                                 
   Raw greens/vegetables/salad                             160     72         89    74   5   56    18   75   15   75   5   71    6   67   21   68   10   77
   Fruit juice                                             193     86         104   87   8   89    24   96   15   75   6   86    7   78   29   91   11   85
   Cold sauce                                              114     52         62    52   3   33    13   52   9    47   3   43    4   44   18   58   7    54
   Cheese                                                  175     78         93    77   7   78    21   84   14   70   6   86    6   67   24   75   13   100
   Tap water                                               30      14         17    15   0   0     2    8    4    20   1   14    0   0    5    16   1    8
   Milk                                                    104     46         63    52   2   22    9    36   9    45   1   14    4   44   14   45   6    46
   Ice with drinks                                         89      40         52    43   4   44    10   40   7    37   4   57    1   11   11   34   4    31
   Ice cream                                               74      33         35    29   2   22    12   48   8    44   3   43    1   11   10   31   5    39
   Reheated buffet food                                    83      38         49    43   4   44    6    24   8    42   5   71    5   56   5    17   6    46
   Chicha                                                  54      25         30    26   4   50    3    12   4    21   4   57    0   0    5    16   3    23
   Street vendor food                                      63      28         44    37   1   11    7    28   5    25   1   14    0   0    3    9    3    21
   Unpeeled fruit                                          64      29         37    31   3   18    3    12   4    21   1   14    2   22   9    29   4    31
  Effect on daily activities                                                                                                                             
   No effect                                               41      18         23    18   1   11    3    12   2    10   2   29    1   11   4    13   0    0
   Stay in bed                                             143     62         66    53   5   56    17   68   17   85   4   57    5   56   29   91   10   71
   Change itinerary                                        30      13         16    13   2   22    2    8    3    15   1   14    1   11   2    6    4    29
   Miss tour                                               52      23         27    22   3   33    3    12   7    35   1   14    1   11   5    16   5    36
   See physician                                           120     52         60    48   5   56    15   60   10   50   2   29    5   56   18   56   11   79
   Hospitalized                                            2       1          1     1    0   0     0    0    0    0    1   14    0   0    0    0    0    0

EAEC = enteroaggregative *Escherichia coli*; ETEC = enterotoxigenic *E. coli*.

###### 

Pathogen counts and frequencies for 230 total samples

                                                   Positive   Percentage of 230   Negative   No. of samples   Total reporting   Tested[\*](#tfn6){ref-type="table-fn"} (%)
  ------------------------------------------------ ---------- ------------------- ---------- ---------------- ----------------- --------------------------------------------
  Norovirus[†](#tfn7){ref-type="table-fn"}         32         13.9                141        63               167               72.6
   Norovirus GI                                    6                                                                            
   Norovirus GII                                   26                                                                           
  ETEC[†](#tfn7){ref-type="table-fn"}              25         10.9                157        48               182               79.1
   St+                                             16                                                                           
   Lt+                                             5                                                                            
   Lt+/St+                                         4                                                                            
  *Campylobacter*[†](#tfn7){ref-type="table-fn"}   20         8.7                 201        9                221               96.1
   *jejuni*                                        16                                                                           
   *coli*                                          3                                                                            
   Other species                                   1                                                                            
  *Shigella*[†](#tfn7){ref-type="table-fn"}        14         6.1                 215        1                229               99.6
   *flexneri*                                      4                                                                            
   *sonnei*                                        9                                                                            
   Other species                                   1                                                                            
  EAEC                                             9          3.9                 45         176              54                23.5
  *Giardia*                                        9          3.9                 218        3                227               98.7
  *Cryptosporidium*                                7          3.0                 217        6                224               97.4
  EPEC                                             0          0.0                 182        48               182               79.1
  *Entamoeba histolytica*                          0          0.0                 227        3                227               98.7
  *Salmonella*                                     0          0.0                 229        1                229               99.6
  Total cases                                                                                0                230               100.0
  Any pathogen                                     104        45.2                                                              
  No pathogen                                      125        54.3                                                              

EAEC = enteroaggregative *Escherichia coli*; EPEC = enteropathogenic *E. coli*.

Percentage of samples tested for specific pathogen.

Subcategories shown are included in the total pathogen counts given.

###### 

Antibiogram by isolate and percent susceptibility

                                                              *n*   AM   AMC   CF   CRO   E    AZM   NA    CIP   GM    SXT   TE
  ----------------------------------------------------------- ----- ---- ----- ---- ----- ---- ----- ----- ----- ----- ----- -----
  *Campylobacter coli*                                        3     33   100   0    33    33   100   33    33    100   0     100
  *Campylobacter jejuni*                                      16    56   100   38   13    88   100   25    25    100   0     44
  Enteroaggregative *Escherichia coli*                        9     56   89    67   89    89   67    100   100   100   78    78
  Enterotoxigenic *E. coli*[\*](#tfn9){ref-type="table-fn"}   27    59   89    63   100   4    78    67    93    96    59    59
  *Shigella flexneri* (Group B)                               4     50   75    25   100   0    100   100   100   100   25    0
  *Shigella sonnei* (Group D)                                 9     0    22    67   100   0    56    89    100   100   0     0

AM = ampicillin; AMC = amoxicillin/clavulanic acid; AZM = azithromycin; CF = cefalotin; CIP = ciprofloxacin; CRO = ceftriaxone; E = erythromycin; GM = gentamycin; NA = nalidixic acid; SXT = sulfamethoxazole/trimethoprim; TE = tetracycline.

Two different resistance patterns were detected in two of the 27 samples and included in the table (*N* = 27).

###### 

Season of presentation by pathogen cases[\*](#tfn11){ref-type="table-fn"}

                      Summer/rainy   Winter/dry   *P* value[†](#tfn12){ref-type="table-fn"}                         
  ------------------- -------------- ------------ ------------------------------------------- -------- ----- ------ -------
  EAEC                **6**          82           7.3                                         **3**    100   3.0    0.072
  ETEC                **18**         82           22.0                                        **7**    100   7.0    0.005
  *Campylobacter*     **5**          95           5.3                                         **15**   126   11.9   0.102
  *Cryptosporidium*   **2**          98           2.0                                         **5**    126   4.0    0.472
  *Giardia*           **5**          100          5.0                                         **4**    127   3.1    0.512
  Norovirus GI        **3**          72           4.2                                         **3**    95    3.2    1.000
  Norovirus GII       **17**         72           23.6                                        **9**    95    9.5    0.017
  Norovirus           **20**         72           27.8                                        **12**   95    12.6   0.017
  *Shigella*          **6**          100          6.0                                         **8**    129   6.2    1.000
  No pathogen         **46**         100          46.0                                        **79**   129   61.2   0.024
  Overall             100                                                                     130                   

EAEC = enteroaggregative *Escherichia coli*; ETEC = enterotoxigenic *E. coli*.

Summer/rainy season refers to participation in study during November through April, and winter/dry season during May through October.

Fisher\'s exact, two-sided χ^2^ of the difference in proportion of season for each pathogen outcome. *P* values \< 0.05 are shown in bold.

###### 

Reported dietary risk factor exposure and ORs for different enteric diseases[\*](#tfn14){ref-type="table-fn"}

                                                                                                           *n*[‡](#tfn16){ref-type="table-fn"}   Reported exposure to risk factor   Crude OR   Adjusted OR[†](#tfn15){ref-type="table-fn"}                                                                                                                          
  -------------------------------------------------------------------------------------------------------- ------------------------------------- ---------------------------------- ---------- --------------------------------------------- ----- --------------------------------------- ------------ ------ --------------------------------------- ------------ ------
  Majority of past week\'s meals consumed in friend\'s home, restaurant, or "other," compared with hotel                                                                                                                                                                                                                                                            
   *Campylobacter*                                                                                         64                                    55                                 9          85.9                                          0.0   0.30                                    0.07--1.27   0.10   0.31                                    0.07--1.43   0.13
   *Cryptosporidium*                                                                                       76                                    66                                 10         86.8                                          0.0   [\*\*\*](#tfn14){ref-type="table-fn"}                       [\*\*\*](#tfn14){ref-type="table-fn"}                
   EAEC                                                                                                    34                                    30                                 4          88.2                                          0.0   1.09                                    0.1--12.1    0.94   1.04                                    0.07--15.1   0.98
   *Giardia*                                                                                               78                                    67                                 11         85.9                                          0.0   1.17                                    0.13--10.5   0.89   1.65                                    0.14--19.4   0.69
   Norovirus GI                                                                                            70                                    59                                 11         84.3                                          0.0   0.93                                    0.1--8.79    0.95   0.78                                    0.08--7.66   0.83
   Norovirus GII                                                                                           76                                    66                                 10         86.8                                          0.0   [\*\*\*](#tfn14){ref-type="table-fn"}                       [\*\*\*](#tfn14){ref-type="table-fn"}                
   Norovirus                                                                                               82                                    71                                 11         86.6                                          0.0   5.43                                    0.66--44.9   0.12   5.42                                    0.59--49.4   0.13
   *Shigella*                                                                                              72                                    62                                 10         86.1                                          0.0   [\*\*\*](#tfn14){ref-type="table-fn"}                       [\*\*\*](#tfn14){ref-type="table-fn"}                
   No pathogen detected                                                                                    151                                   129                                22         85.4                                          0.0   0.73                                    0.2--2.67    0.63   0.76                                    0.21--2.83   0.69
   ETEC                                                                                                    182                                   159                                23         87.4                                          0.0   1.0 (ref)                                                   1.0 (ref)                                            
  Consumed raw green vegetables or salads in past week                                                                                                                                                                                                                                                                                                              
   *Campylobacter*                                                                                         61                                    46                                 15         75.4                                          4.7   0.97                                    0.28--3.34   0.96   0.12                                    0.32--4.69   0.77
   *Cryptosporidium*                                                                                       73                                    54                                 19         74.0                                          3.9   0.87                                    0.15--4.89   0.87   0.67                                    0.11--3.91   0.65
   EAEC                                                                                                    33                                    23                                 10         69.7                                          2.9   0.42                                    0.08--2.08   0.29   0.44                                    0.08--2.43   0.34
   *Giardia*                                                                                               75                                    55                                 20         73.3                                          3.8   0.57                                    0.12--2.63   0.47   0.29                                    0.05--1.71   0.17
   Norovirus GI                                                                                            68                                    52                                 16         76.5                                          2.9   [\*\*\*](#tfn14){ref-type="table-fn"}                       [\*\*\*](#tfn14){ref-type="table-fn"}                
   Norovirus GII                                                                                           73                                    52                                 21         71.2                                          3.9   0.44                                    0.15--1.32   0.14   0.33                                    0.09--1.18   0.09
   Norovirus                                                                                               79                                    58                                 21         73.4                                          3.7   0.67                                    0.24--1.92   0.46   0.56                                    0.17--1.78   0.32
   *Shigella*                                                                                              69                                    52                                 17         75.4                                          4.2   1.11                                    0.27--4.62   0.89   1.10                                    0.25--4.9    0.90
   No pathogen detected                                                                                    146                                   107                                39         73.3                                          3.3   1.08                                    0.41--2.83   0.87   1.07                                    0.41--2.82   0.89
   ETEC                                                                                                    177                                   126                                51         71.2                                          2.7   1.0 (ref)                                                   1.0 (ref)                                            
  Consumed fruit juice in past week                                                                                                                                                                                                                                                                                                                                 
   *Campylobacter*                                                                                         62                                    53                                 9          85.5                                          3.1   0.32                                    0.08--1.34   0.12   0.26                                    0.06--1.21   0.09
   *Cryptosporidium*                                                                                       74                                    63                                 11         85.1                                          2.6   1.05                                    0.11--9.7    0.96   1.12                                    0.11--11.8   0.92
   EAEC                                                                                                    34                                    32                                 2          94.1                                          0.0   0.33                                    0.02--5.97   0.46   0.28                                    0.01--8.64   0.47
   *Giardia*                                                                                               76                                    65                                 11         85.5                                          2.6   0.46                                    0.08--2.63   0.38   0.66                                    0.1--4.55    0.67
   Norovirus GI                                                                                            69                                    58                                 11         84.1                                          1.4   0.33                                    0.05--2.1    0.24   0.23                                    0.03--1.81   0.16
   Norovirus GII                                                                                           75                                    65                                 10         86.7                                          1.3   3.72                                    0.44--31.4   0.23   9.11                                    0.86--95.8   0.07
   Norovirus                                                                                               81                                    69                                 12         85.2                                          1.2   1.50                                    0.37--6.08   0.57   2.55                                    0.53--12.2   0.24
   *Shigella*                                                                                              70                                    60                                 10         85.7                                          2.8   0.90                                    0.17--4.83   0.90   0.87                                    0.15--4.94   0.87
   No pathogen detected                                                                                    146                                   128                                18         87.7                                          3.3   0.54                                    0.12--2.52   0.43   0.55                                    0.12--2.56   0.44
   ETEC                                                                                                    178                                   157                                21         88.2                                          2.2   1.0 (ref)                                                   1.0 (ref)                                            
  Consumed cold sauce in the past week                                                                                                                                                                                                                                                                                                                              
   *Campylobacter*                                                                                         60                                    31                                 29         51.7                                          6.3   0.78                                    0.26--2.31   0.65   0.85                                    0.28--2.59   0.78
   *Cryptosporidium*                                                                                       72                                    38                                 34         52.8                                          5.3   0.64                                    0.13--3.1    0.58   0.59                                    0.12--2.95   0.52
   EAEC                                                                                                    34                                    16                                 18         47.1                                          0.0   0.46                                    0.09--2.27   0.34   0.38                                    0.07--2.18   0.28
   *Giardia*                                                                                               74                                    39                                 35         52.7                                          5.1   0.50                                    0.11--2.27   0.37   0.35                                    0.07--1.86   0.22
   Norovirus GI                                                                                            67                                    32                                 35         47.8                                          4.3   0.52                                    0.09--3.03   0.47   0.54                                    0.09--3.28   0.50
   Norovirus GII                                                                                           72                                    38                                 34         52.8                                          5.3   2.43                                    0.8--7.35    0.12   1.77                                    0.52--6.03   0.36
   Norovirus                                                                                               78                                    40                                 38         51.3                                          4.9   1.68                                    0.64--4.41   0.29   1.29                                    0.44--3.74   0.64
   *Shigella*                                                                                              68                                    37                                 31         54.4                                          5.6   0.97                                    0.29--3.27   0.96   0.98                                    0.28--3.34   0.97
   No pathogen detected                                                                                    145                                   75                                 70         51.7                                          4.0   1.09                                    0.47--2.54   0.85   1.11                                    0.47--2.6    0.82
   ETEC                                                                                                    177                                   90                                 87         50.8                                          2.7   1.0 (ref)                                                   1.0 (ref)                                            
  Consumed cheese in the past week                                                                                                                                                                                                                                                                                                                                  
   *Campylobacter*                                                                                         62                                    50                                 12         80.6                                          3.1   0.39                                    0.11--1.41   0.15   0.39                                    0.1--1.46    0.16
   *Cryptosporidium*                                                                                       74                                    61                                 13         82.4                                          2.6   1.31                                    0.14--11.9   0.81   1.24                                    0.13--12.3   0.85
   EAEC                                                                                                    34                                    28                                 6          82.4                                          0.0   0.67                                    0.1--4.46    0.68   0.66                                    0.09--4.98   0.69
   *Giardia*                                                                                               76                                    62                                 14         81.6                                          2.6   0.32                                    0.07--1.55   0.16   0.45                                    0.07--2.67   0.38
   Norovirus GI                                                                                            69                                    57                                 12         82.6                                          1.4   1.06                                    0.11--9.97   0.96   0.94                                    0.1--9.16    0.96
   Norovirus GII                                                                                           75                                    59                                 16         78.7                                          1.3   0.52                                    0.16--1.68   0.27   0.65                                    0.18--2.38   0.52
   Norovirus                                                                                               81                                    64                                 17         79.0                                          1.2   0.60                                    0.2--1.82    0.37   0.71                                    0.22--2.32   0.57
   *Shigella*                                                                                              70                                    58                                 12         82.9                                          2.8   [\*\*\*](#tfn14){ref-type="table-fn"}                       [\*\*\*](#tfn14){ref-type="table-fn"}                
   No pathogen detected                                                                                    147                                   115                                32         78.2                                          2.6   0.60                                    0.19--1.9    0.39   0.60                                    0.19--1.91   0.39
   ETEC                                                                                                    179                                   137                                42         76.5                                          1.6   1.0 (ref)                                                   1.0 (ref)                                            
  Consumed tap water in the past week                                                                                                                                                                                                                                                                                                                               
   *Campylobacter*                                                                                         61                                    8                                  53         13.1                                          4.7   2.32                                    0.51--10.4   0.28   2.22                                    0.49--10.2   0.30
   *Cryptosporidium*                                                                                       73                                    9                                  64         12.3                                          3.9   1.21                                    0.13--11.4   0.87   0.64                                    0.16--17.1   0.68
   EAEC                                                                                                    33                                    2                                  31         6.1                                           2.9   [\*\*\*](#tfn14){ref-type="table-fn"}                       [\*\*\*](#tfn14){ref-type="table-fn"}                
   *Giardia*                                                                                               75                                    8                                  67         10.7                                          3.8   [\*\*\*](#tfn14){ref-type="table-fn"}                       [\*\*\*](#tfn14){ref-type="table-fn"}                
   Norovirus GI                                                                                            68                                    6                                  62         8.8                                           2.9   [\*\*\*](#tfn14){ref-type="table-fn"}                       [\*\*\*](#tfn14){ref-type="table-fn"}                
   Norovirus GII                                                                                           73                                    9                                  64         12.3                                          3.9   2.61                                    0.62--11     0.19   3.00                                    0.58--15.5   0.19
   Norovirus                                                                                               79                                    9                                  70         11.4                                          3.7   1.87                                    0.46--7.65   0.39   1.97                                    0.42--9.18   0.39
   *Shigella*                                                                                              69                                    8                                  61         11.6                                          4.2   0.58                                    0.07--5.2    0.63   0.59                                    0.07--5.26   0.63
   No pathogen detected                                                                                    142                                   20                                 122        14.1                                          6.0   1.25                                    0.34--4.63   0.74   1.27                                    0.34--4.75   0.72
   ETEC                                                                                                    173                                   23                                 150        13.3                                          4.9   1.0 (ref)                                                   1.0 (ref)                                            
  Consumed milk in the past week                                                                                                                                                                                                                                                                                                                                    
   *Campylobacter*                                                                                         63                                    26                                 37         41.3                                          1.6   1.25                                    0.43--3.66   0.68   1.26                                    0.42--3.74   0.68
   *Cryptosporidium*                                                                                       75                                    31                                 44         41.3                                          1.3   0.21                                    0.02--1.85   0.16   0.17                                    0.02--1.58   0.12
   EAEC                                                                                                    34                                    11                                 23         32.4                                          0.0   0.51                                    0.09--2.98   0.45   0.44                                    0.07--2.71   0.37
   *Giardia*                                                                                               77                                    33                                 44         42.9                                          1.3   1.38                                    0.32--5.98   0.67   1.38                                    0.28--6.69   0.69
   Norovirus GI                                                                                            69                                    28                                 41         40.6                                          1.4   1.52                                    0.28--8.14   0.63   1.42                                    0.26--7.84   0.68
   Norovirus GII                                                                                           74                                    32                                 42         43.2                                          2.6   1.25                                    0.44--3.57   0.67   1.38                                    0.42--4.49   0.59
   Norovirus                                                                                               80                                    35                                 45         43.8                                          2.4   1.28                                    0.5--3.32    0.61   1.42                                    0.5--4.01    0.51
   *Shigella*                                                                                              71                                    30                                 41         42.3                                          1.4   1.21                                    0.36--4.07   0.75   1.20                                    0.36--4.06   0.77
   No pathogen detected                                                                                    148                                   72                                 76         48.6                                          2.0   2.02                                    0.83--4.88   0.12   2.11                                    0.87--5.14   0.10
   ETEC                                                                                                    178                                   83                                 95         46.6                                          2.2   1.0 (ref)                                                   1.0 (ref)                                            
  Consumed ice with drinks in the past week                                                                                                                                                                                                                                                                                                                         
   *Campylobacter*                                                                                         61                                    23                                 38         37.7                                          4.7   0.95                                    0.31--2.91   0.93   1.05                                    0.33--3.29   0.94
   *Cryptosporidium*                                                                                       73                                    29                                 44         39.7                                          3.9   2.19                                    0.45--10.6   0.33   1.98                                    0.39--9.95   0.41
   EAEC                                                                                                    34                                    14                                 20         41.2                                          0.0   1.20                                    0.26--5.59   0.82   0.94                                    0.18--4.93   0.94
   *Giardia*                                                                                               75                                    28                                 47         37.3                                          3.8   0.21                                    0.03--1.82   0.16   0.13                                    0.01--1.32   0.08
   Norovirus GI                                                                                            68                                    25                                 43         36.8                                          2.9   0.32                                    0.04--2.88   0.31   0.30                                    0.03--2.75   0.29
   Norovirus GII                                                                                           74                                    27                                 47         36.5                                          2.6   0.92                                    0.31--2.67   0.87   0.88                                    0.28--2.8    0.83
   Norovirus                                                                                               80                                    28                                 52         35.0                                          2.4   0.76                                    0.28--2.05   0.58   0.73                                    0.25--2.08   0.55
   *Shigella*                                                                                              69                                    27                                 42         39.1                                          4.2   0.64                                    0.18--2.32   0.50   0.63                                    0.17--2.32   0.49
   No pathogen detected                                                                                    148                                   63                                 85         42.6                                          2.0   1.01                                    0.43--2.39   0.98   1.00                                    0.42--2.42   0.99
   ETEC                                                                                                    180                                   71                                 109        39.4                                          1.1   1.0 (ref)                                                   1.0 (ref)                                            
  Consumed ice cream in the past week                                                                                                                                                                                                                                                                                                                               
   *Campylobacter*                                                                                         61                                    26                                 35         42.6                                          4.7   1.11                                    0.37--3.37   0.85   1.23                                    0.39--3.88   0.72
   *Cryptosporidium*                                                                                       73                                    30                                 43         41.1                                          3.9   1.08                                    0.22--5.24   0.92   0.95                                    0.19--4.82   0.95
   EAEC                                                                                                    34                                    14                                 20         41.2                                          0.0   0.31                                    0.05--1.79   0.19   0.33                                    0.05--2.14   0.25
   *Giardia*                                                                                               75                                    28                                 47         37.3                                          3.8   0.21                                    0.03--1.82   0.16   0.15                                    0.02--1.51   0.11
   Norovirus GI                                                                                            67                                    23                                 44         34.3                                          4.3   0.95                                    0.16--5.63   0.96   0.93                                    0.15--5.57   0.94
   Norovirus GII                                                                                           73                                    25                                 48         34.2                                          3.9   0.77                                    0.25--2.33   0.64   0.58                                    0.16--2.03   0.39
   Norovirus                                                                                               79                                    27                                 52         34.2                                          3.7   0.80                                    0.29--2.17   0.66   0.71                                    0.24--2.08   0.53
   *Shigella*                                                                                              69                                    28                                 41         40.6                                          4.2   0.90                                    0.26--3.09   0.86   0.90                                    0.26--3.1    0.86
   No pathogen detected                                                                                    149                                   48                                 101        32.2                                          1.3   0.40                                    0.17--0.94   0.04   0.40                                    0.17--0.96   0.04
   ETEC                                                                                                    180                                   57                                 123        31.7                                          1.1   1.0 (ref)                                                   1.0 (ref)                               --           
  Consumed food from a reheated buffet in the past week                                                                                                                                                                                                                                                                                                             
   *Campylobacter*                                                                                         61                                    21                                 40         34.4                                          4.7   1.62                                    0.53--4.98   0.40   1.80                                    0.57--5.69   0.32
   *Cryptosporidium*                                                                                       73                                    27                                 46         37.0                                          3.9   5.00                                    0.9--27.9    0.07   4.91                                    0.86--27.9   0.07
   EAEC                                                                                                    34                                    10                                 24         29.4                                          0.0   2.53                                    0.51--12.6   0.26   3.93                                    0.63--24.7   0.14
   *Giardia*                                                                                               75                                    29                                 46         38.7                                          3.8   2.99                                    0.66--13.6   0.16   3.07                                    0.61--15.5   0.17
   Norovirus GI                                                                                            68                                    24                                 44         35.3                                          2.9   1.95                                    0.36--10.5   0.44   1.96                                    0.36--10.8   0.44
   Norovirus GII                                                                                           72                                    21                                 51         29.2                                          5.3   0.10                                    0.01--0.91   0.03   0.07                                    0.01--0.71   0.02
   Norovirus                                                                                               78                                    24                                 54         30.8                                          4.9   0.34                                    0.1--1.14    0.08   0.36                                    0.1--1.29    0.12
   *Shigella*                                                                                              69                                    25                                 44         36.2                                          4.2   1.67                                    0.49--5.67   0.41   1.67                                    0.49--5.71   0.41
   No pathogen detected                                                                                    141                                   55                                 86         39.0                                          6.6   2.48                                    0.93--6.62   0.07   2.47                                    0.92--6.64   0.07
   ETEC                                                                                                    171                                   64                                 107        37.4                                          6.0   1.0 (ref)                                                   1.0 (ref)                                            
  Consumed chicha in the past week                                                                                                                                                                                                                                                                                                                                  
   *Campylobacter*                                                                                         61                                    11                                 50         18.0                                          4.7   1.33                                    0.34--5.24   0.68   1.43                                    0.35--5.77   0.62
   *Cryptosporidium*                                                                                       73                                    17                                 56         23.3                                          3.9   5.44                                    1.08--27.3   0.04   5.78                                    1.08--30.9   0.04
   EAEC                                                                                                    33                                    7                                  26         21.2                                          2.9   7.33                                    1.17--46.1   0.03   9.26                                    1.08--79.2   0.04
   *Giardia*                                                                                               75                                    14                                 61         18.7                                          3.8   [\*\*\*](#tfn14){ref-type="table-fn"}                       [\*\*\*](#tfn14){ref-type="table-fn"}                
   Norovirus GI                                                                                            67                                    13                                 54         19.4                                          4.3   1.04                                    0.11--10.2   0.97   1.08                                    0.11--10.9   0.95
   Norovirus GII                                                                                           74                                    15                                 59         20.3                                          2.6   0.98                                    0.27--3.52   0.97   0.98                                    0.26--3.71   0.97
   Norovirus                                                                                               79                                    16                                 63         20.3                                          3.7   0.98                                    0.3--3.19    0.97   0.89                                    0.26--3.04   0.85
   *Shigella*                                                                                              69                                    14                                 55         20.3                                          4.2   1.23                                    0.29--5.23   0.78   1.23                                    0.29--5.25   0.78
   No pathogen detected                                                                                    142                                   34                                 108        23.9                                          6.0   1.92                                    0.61--6.02   0.26   1.91                                    0.61--6.02   0.27
   ETEC                                                                                                    172                                   42                                 130        24.4                                          5.5   1.0 (ref)                                                   1.0 (ref)                                            
  Consumed street vendor food in the past week                                                                                                                                                                                                                                                                                                                      
   *Campylobacter*                                                                                         63                                    17                                 46         27.0                                          1.6   0.86                                    0.26--2.89   0.81   0.89                                    0.26--3.08   0.86
   *Cryptosporidium*                                                                                       75                                    21                                 54         28.0                                          1.3   0.40                                    0.05--3.54   0.41   0.37                                    0.04--3.33   0.37
   EAEC                                                                                                    34                                    8                                  26         23.5                                          0.0   0.32                                    0.03--3.06   0.32   0.27                                    0.02--2.96   0.28
   *Giardia*                                                                                               77                                    20                                 57         26.0                                          1.3   [\*\*\*](#tfn14){ref-type="table-fn"}                       [\*\*\*](#tfn14){ref-type="table-fn"}                
   Norovirus GI                                                                                            70                                    17                                 53         24.3                                          0.0   [\*\*\*](#tfn14){ref-type="table-fn"}                       [\*\*\*](#tfn14){ref-type="table-fn"}                
   Norovirus GII                                                                                           76                                    16                                 60         21.1                                          0.0   0.14                                    0.02--1.17   0.07   0.14                                    0.02--1.21   0.07
   Norovirus                                                                                               82                                    16                                 66         19.5                                          0.0   0.11                                    0.01--0.88   0.04   0.11                                    0.01--0.87   0.04
   *Shigella*                                                                                              71                                    20                                 51         28.2                                          1.4   0.64                                    0.16--2.6    0.53   0.67                                    0.16--2.78   0.58
   No pathogen detected                                                                                    146                                   52                                 94         35.6                                          3.3   1.30                                    0.52--3.24   0.57   1.36                                    0.54--3.4    0.52
   ETEC                                                                                                    178                                   49                                 129        27.5                                          2.2   1.0 (ref)                                                   1.0 (ref)                                            
  Consumed unpeeled fruit in the past week                                                                                                                                                                                                                                                                                                                          
   *Campylobacter*                                                                                         61                                    12                                 49         19.7                                          4.7   1.13                                    0.3--4.35    0.86   1.24                                    0.31--4.92   0.76
   *Cryptosporidium*                                                                                       73                                    17                                 56         23.3                                          3.9   0.52                                    0.06--4.66   0.56   0.47                                    0.05--4.28   0.50
   EAEC                                                                                                    34                                    6                                  28         17.6                                          0.0   3.67                                    0.58--23     0.17   2.85                                    0.43--18.9   0.28
   *Giardia*                                                                                               75                                    18                                 57         24.0                                          3.8   1.06                                    0.2--5.79    0.94   0.75                                    0.12--4.68   0.76
   Norovirus GI                                                                                            68                                    15                                 53         22.1                                          2.9   1.89                                    0.31--11.4   0.49   1.68                                    0.27--10.5   0.58
   Norovirus GII                                                                                           73                                    20                                 53         27.4                                          3.9   1.84                                    0.6--5.65    0.29   1.89                                    0.55--6.43   0.31
   Norovirus                                                                                               79                                    22                                 57         27.8                                          3.7   1.77                                    0.63--4.96   0.27   1.82                                    0.61--5.43   0.28
   *Shigella*                                                                                              69                                    16                                 53         23.2                                          4.2   1.63                                    0.43--6.22   0.48   1.67                                    0.42--6.68   0.47
   No pathogen detected                                                                                    146                                   41                                 105        28.1                                          3.3   2.45                                    0.79--7.62   0.12   2.44                                    0.78--7.63   0.12
   ETEC                                                                                                    177                                   50                                 127        28.2                                          2.7   1.0 (ref)                                                   1.0 (ref)                                            

CI = confidence interval; EAEC = enteroaggregative *Escherichia coli*; ETEC = enterotoxigenic *E. coli*; OR = odds ratio.

List-wise deletion was used to handle missing variables, and the asterisk (\*\*\*) indicates that exposure to a risk factor was a perfect predictor of the outcome.

Adjusted for age and gender.

The number of cases of both ETEC and the respective pathogen (or cases without pathogen identified, as relevant) included in each case--case variable.

"Unknown" calculated with denominator of number of observations for each outcome variable.
